Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Impairment in Systemic Lupus Erythematosus
NCT03527472Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2018
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in systemic lupus erythematosus (SLE), sponsored by Vanderbilt University Medical Center. Started Aug 2018; status: completed.
02
Drugs
memantine
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03527472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527472.